irbesartan Tablets 300 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Malaysia
GMP approvals
PICS
Manufacturer #540

Manufacturer usually replies in 18 days

IRBESARTAN manufacturers

Irbesartan is an angiotensin II receptor antagonist that is widely used to treat high blood pressure, helping to prevent heart attacks, strokes, and kidney problems. The medication is manufactured in white to yellowish-white scored film-coated oval tablet form and is taken orally. The typical dose is 150mg to 30mg once a day. Lower doses may be prescribed to people who are over 75 or who have kidney or liver problems. With millions of people across the world affected by hypertension (high blood pressure), there is a huge demand for supplies of the medication from Irbesartan manufacturers. Distributors and suppliers make sure there is enough available to keep up with supply. Irbesartan manufacturers also produce generic versions of the medication. Irbesartan was developed by Sanofi Research, which is now part of Sanofi-Aventis, a French multinational company that is one of the leading pharmaceutical manufacturers with a strong track record in the global marketplace. Irbesartan was patented in 1990 and approved for medical use seven years later. The drug is sold and distributed under the trade names Aprovel, Karvea, and Avapro, and is available in more than 80 countries. In 2016, Irbesartan was the 171st most prescribed medication in the United States, with more than 3.6 million prescriptions. According to large-scale trials, which are often mentioned in international guidelines, the medication is also the only ARB (angiotensin II receptor antagonist) with renoprotective effects for people with hypertensive type 2 diabetes. Follow all Instructions on your medicine package and label. It is wise to tell your healthcare providers about all your medical allergies, illnesses, and all medicines you use. Before taking IRBESARTAN: You should not use This medical drug if you are allergic to it. This drug may also be used for purposes that may not have been listed in this medication guide. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified rosiglitazone manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform.

How does IRBESARTAN work?

The usage of this pharmaceutical substance: Read the Guide and, if available, the Patient Information Leaflet that will be provided by your pharmacist before you start taking IRBESARTAN. If you have any questions related to this medical remedy, ask your pharmacist or doctor. As angiotensin, Irbesartan works by blocking the effects of angiotensin II, a peptide hormone that causes vasoconstriction, the constriction of blood vessels. Consequently, the medication prevents blood vessels from narrowing, which lowers blood pressure and improves blood flow. It has a long half-life in blood and a 24-hour-lasting blood pressure-lowering effect. It can be taken by adults aged 18 or over but may not be suitable for some people. For example, it is not usually prescribed to pregnant women.

The Wholesale Price of IRBESARTAN?

According to Drug Patent Watch, the average cost to pharmacies per 300mg tablet in 2019 was $0.35424. The average price of a 150mg tablet was $0.28184. In the United States, the average cost without insurance for 30 x 300mg tablets is $117.99. Online pharmacies also sell this medication. Buyers looking for an easy and convenient way to source and order Irbesartan can search online using Pipelinepharma's marketplace. Through our strict vetting and quality control procedures, you will only find verified Irbesartan manufacturers and suppliers.

Sourcing the IRBESARTAN Manufacturers and Suppliers

If you are looking to find manufacturers and suppliers of IRBESARTAN, locate them quickly using Pipelinepharma's online marketplace. With this convenient B2B platform, you can order types of medications and quantities you require from companies that have passed our stringent vetting and quality control procedures. Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of IRBESARTAN offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for this substance manufacturer and these substance suppliers that you are looking for. These also enable you to check the dossier status of this medicine, and the GMP approvals of the different variants of IRBESARTAN. Also, each manufacturer or supplier product description contains essential information about this substance including clinical data, stability zones, countries where IRBESARTAN is already registered in. Manufacturers also have special, and delivery terms.

Establishing commercial ties

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over these medicine offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and ordering process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers or suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that this medicine manufacturers list has, we qualify their companies before they are onboarded on the platform. This allows us to screen IRBESARTAN manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.